Steve Seedhouse
Stock Analyst at Cantor Fitzgerald
(2.88)
# 1,772
Out of 4,996 analysts
4
Total ratings
75%
Success rate
23.12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Steve Seedhouse
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APLS Apellis Pharmaceuticals | Maintains: Overweight | $39 → $40 | $22.39 | +78.65% | 1 | Aug 1, 2025 | |
| INVA Innoviva | Initiates: Overweight | $26 | $18.86 | +37.86% | 1 | Jul 11, 2025 | |
| TVRD Tvardi Therapeutics | Initiates: Overweight | $52 | $36.32 | +43.17% | 1 | Jul 11, 2025 | |
| HROW Harrow | Initiates: Overweight | $76 | $47.10 | +61.36% | 1 | Jul 11, 2025 |
Apellis Pharmaceuticals
Aug 1, 2025
Maintains: Overweight
Price Target: $39 → $40
Current: $22.39
Upside: +78.65%
Innoviva
Jul 11, 2025
Initiates: Overweight
Price Target: $26
Current: $18.86
Upside: +37.86%
Tvardi Therapeutics
Jul 11, 2025
Initiates: Overweight
Price Target: $52
Current: $36.32
Upside: +43.17%
Harrow
Jul 11, 2025
Initiates: Overweight
Price Target: $76
Current: $47.10
Upside: +61.36%